info@seagull-health.com
SeagullHealth
语言:
search
new
Use of Reblozyl in specific populations
503
Article source: Seagull Pharmacy
Jul 25, 2025

This article introduces the use of Reblozyl in specific populations to help patients avoid risks.

Use of Reblozyl in specific populations

Pregnancy

According to the results of animal studies, pregnant women using Reblozyl may cause harm to the fetus.

Lactation

Animal studies have shown that breast-fed children may experience serious adverse reactions, so it is recommended that lactating patients not breastfeed during treatment with Reblozyl and within 3 months after the last dose.

Women and men with fertility plans

It is recommended that women with fertility plans take a pregnancy test before receiving Reblozyl treatment.

Pregnant women may suffer embryo-fetal damage during treatment with Reblozyl, and female patients with fertility plans are advised to take effective contraceptive measures during treatment and for at least 3 months after the last dose.

According to the results of animal studies, Reblozyl may impair the fertility of female animals. The adverse effects on the fertility of female organisms are reversible after a 14-week recovery period.

Use in pediatric patients

The safety and efficacy of Reblozyl in pediatric patients have not been established. Based on animal studies, Reblozyl is not recommended for use in pediatric patients.

Use in Elderly Patients

Clinical trials for use in elderly patients with beta-thalassemia did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently from younger patients.

In clinical studies of Reblozyl for the treatment of MDS-RS and MDS/MPN-RS-T anemia, 206 (79%) patients were ≥ 65 years of age and 93 (36%) patients were ≥ 75 years of age. There were no differences in safety or effectiveness between elderly and younger patients.

Precautions

Before receiving Reblozyl, tell your doctor if you have or have had blood clots; Have or have had high blood pressure (hypertension); Take hormone replacement therapy or birth control pills (oral contraceptives); Have had your spleen removed (splenectomy); Do you smoke;Are you pregnant or planning to become pregnant.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Where can I buy genuine Enbrel?
As an important biological agent, Enbrel is widely used in the treatment of moderate and severe active rheumatoid arthritis, moderate and severe plaque psoriasis in adults, and active ankylosing ...
What are the side effects of Enbrel?
Enbrel is a drug commonly used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Although it often performs well in treating these diseases, some side effects may occur during...
What are the indications and applicable populations of Enbrel?
Some autoimmune diseases, such as rheumatoid arthritis and psoriasis, have brought great trouble to patients' daily lives. For these diseases, Enbrel, as a biological agent, has gradually become a...
What disease does Enbrel treat?
Enbrel is widely used in the treatment of rheumatoid arthritis, psoriasis and ankylosing spondylitis, but it is not suitable for all patients. Before using Enbrel, the doctor will evaluate the pa...
Adverse reactions reported in Reblozyl clinical trials
The most common adverse reactions (>10%) during the use of Reblozyl were fatigue, headache, musculoskeletal pain, arthralgia, dizziness/vertigo, nausea, diarrhea, cough, abdominal pain, dyspne...
Clinical trial efficacy of Reblozyl
Reblozyl is a recombinant fusion protein that binds to multiple endogenous TGF-β superfamily ligands, thereby reducing Smad2/3 signaling. Reblozyl promotes erythrocyte maturation by differen...
Reblozyl instructions
Luspatercept (REBLOZYL), developed by Bristol-Myers Squibb, has been approved for marketing in many countries for the treatment of adult patients with β-thalassemia who require regular red blood cell ...
How effective is apelisib combined with Fulvestrant in treating breast cancer?
Studies have shown that inhibition of PI3K by Apellis treatment can induce increased transcription of the estrogen receptor (ER) in breast cancer cells. In xenograft models of ER-positive, PIK3CA-muta...
Related Articles
Reblozyl instructions
Luspatercept (REBLOZYL), developed by Bristol-Myers Squibb, has been approved for marketing in many countries for the treatment of adult patients with β-thalassemia who require regular red blood cell ...
Clinical trial efficacy of Reblozyl
Reblozyl is a recombinant fusion protein that binds to multiple endogenous TGF-β superfamily ligands, thereby reducing Smad2/3 signaling. Reblozyl promotes erythrocyte maturation by differen...
Adverse reactions reported in Reblozyl clinical trials
The most common adverse reactions (>10%) during the use of Reblozyl were fatigue, headache, musculoskeletal pain, arthralgia, dizziness/vertigo, nausea, diarrhea, cough, abdominal pain, dyspne...
Use of Reblozyl in specific populations
This article introduces the use of Reblozyl in specific populations to help patients avoid risks.Use of Reblozyl in specific populationsPregnancyAccording to the results of animal studies, pregnant wo...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved